Regencell Bioscience Holdings Stock Forecast

Sell candidate since Jun 04, 2026 Loss -77.35%

The Regencell Bioscience Holdings Limited stock price gained 5.02% on the last trading day (Friday, 17th Jul 2026), rising from $4.78 to $5.02. During the last trading day the stock fluctuated 13.30% from a day low at $4.51 to a day high of $5.11. The price has fallen in 6 of the last 10 days and is down by -21.19% for this period. Volume fell on the last day by -145 thousand shares and in total, 148 thousand shares were bought and sold for approximately $745.21 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $4.29 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -76.64% during the next 3 months and, with a 90% probability hold a price between $1.00 and $2.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

RGC Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, July 16, 2026, and so far it has risen 5.02%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Regencell Bioscience Holdings Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $5.37 and $12.83. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Regencell Bioscience Holdings Limited stock

Regencell Bioscience Holdings Limited finds support from accumulated volume at $4.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.600 between high and low, or 13.30%. For the last week the stock has had daily average volatility of 15.14%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RGC) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Regencell Bioscience Holdings Limited to open at $4.88, and during the day (based on 14 day Average True Range), to move between $4.31 and $5.73, which gives a possible trading interval of +/-$1.42 (+/-32.86%) up or down from last closing price. If Regencell Bioscience Holdings Limited takes out the full calculated possible swing range there will be an estimated 32.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $5.05 (0.60%) than the support at $4.78 (4.78%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Regencell Bioscience Holdings Limited stock A Buy?

Regencell Bioscience Holdings Limited holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.585 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $4.88 ( 2.79%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk